Omega Fund Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Omega Fund Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-753,564	Closed	-$57.3M	–	12
2017 Q4	$34.4M	Sell	753,564 -321,048	-30%	-$16M	24.9%	2
2017 Q3	$48.2M	Sell	1,074,612 -154,900	-13%	-$5.28M	27.27%	2
2017 Q2	$36.8M	Hold	1,229,512	–	–	22.93%	2
2017 Q1	$27.3M	Hold	1,229,512	–	–	17.73%	2
2016 Q4	$23.2M	Hold	1,229,512	–	–	18.81%	2
2016 Q3	$36.9M	Hold	1,229,512	–	–	28.17%	1
2016 Q2	$47.3M	Hold	1,229,512	–	–	35.06%	1
2016 Q1	$46.8M	Hold	1,229,512	–	–	32.48%	1
2015 Q4	$54.1M	Sell	1,229,512 -100,000	-8%	-$4.96M	30.09%	1
2015 Q3	$54.1M	Sell	1,329,512 -45,488	-3%	-$1.99M	30.46%	1
2015 Q2	$73.3M	Hold	1,375,000	–	–	37.02%	1
2015 Q1	$83.4M	Sell	1,375,000 -50,000	-4%	-$2.43M	36.07%	1
2014 Q4	$74.4M	Buy	+1,425,000	New	+$63.8M	34.23%	2

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Omega Fund Management's JUNO Position: Q1 2018 in Review

Omega Fund Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 753,564 shares — an estimated $57.3M sold.

Omega Fund Management first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $83.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Omega Fund Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Omega Fund Management sold 753,564 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $57.3M.
Omega Fund Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
Omega Fund Management's Juno Therapeutics, Inc. position peaked at $83.4M in Q1 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Omega Fund Management's 13F filing for Q1 2018, filed 4 May 2018.